secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K/A
Filed at:   2022-08-15T23:59:59+00:00
Accession:  0001193125-22-221331
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biote corrects Q2 2022 net income down $9.4M; operating loss widened by $9.4M on omitted deal costs
--------------------------------------------------------------------------------

- Corrected Q2 2022 net income $40.3M (was $49.7M); operating loss $(85.6M) (was $(76.2M)).
- Six-month net income now $49.7M (was $59.1M); operating loss $(75.8M) (was $(66.4M)).
- Omitted $7.2M in excess fair value of shares and $2.2M consulting costs related to May 2022 business combination.
- Revenue of $47.5M and adjusted EBITDA of $13.1M for Q2 2022 were not impacted.
- Full-year 2022 guidance for revenue and adjusted EBITDA remains unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312522221331/0001193125-22-221331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312522221331/d342876d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-221331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer